Unique proprietary platform that collects and links outcomes (efficacy, safety and key milestone survival rates) to granular clinical programs and program design. Rapid results allow focus on foundational analysis and strategy development. 

 

Updated Information
  • Monthly
    • New trials and read-outs
  • Quarterly
    • Changes in trial design
    • Updated recruitment status
    • Additions to patient cohorts
  • After key conferences
    • GU, GI, AACR, ASCO, EHA, ESMO, LUNG, SABC, ASH, SITCs, ICLLM
Dataset Differentiators
  • Outcomes by molecule, patient characteristics, segments, prior therapy and immunotherapy resistance
  • Outcomes with comparator at each endpoint
  • Milestone Data
  • Review criteria followed to report outcomes